On the improvement of inhibitory response control and visuospatial attention by indirect and direct adrenoceptor agonists
T Pattij, D Schetters, ANM Schoffelmeer… - …, 2012 - Springer
Rationale The clinical efficacy of the monoamine and noradrenaline transporter inhibitors
methylphenidate and atomoxetine in attention deficit/hyperactivity disorder implicates …
methylphenidate and atomoxetine in attention deficit/hyperactivity disorder implicates …
The use of reaction time distributions to study attention in male rats: the effects of atomoxetine and guanfacine
ZV Redding, P Chawla, KE Sabol - Psychopharmacology, 2019 - Springer
Rationale Norepinephrine (NE) is involved in the control of sustained attention. Studies of
sustained attention in humans include measures of reaction time (RT) and RT variability …
sustained attention in humans include measures of reaction time (RT) and RT variability …
Impaired flexibility in decision making in rats after administration of the pharmacological stressor yohimbine
AL Schwager, AK Haack, SA Taha - Psychopharmacology, 2014 - Springer
Rationale Stress-induced disruption of decision making has been hypothesized to contribute
to drug-seeking behaviors and addiction. Noradrenergic signaling plays a central role in …
to drug-seeking behaviors and addiction. Noradrenergic signaling plays a central role in …
Noradrenergic modulation of risk/reward decision making
DR Montes, CM Stopper, SB Floresco - Psychopharmacology, 2015 - Springer
Rationale Catecholamine transmission modulates numerous cognitive and reward-related
processes that can subserve more complex functions such as cost/benefit decision making …
processes that can subserve more complex functions such as cost/benefit decision making …
Atomoxetine and reward size equally improve task engagement and perceptual decisions but differently affect movement execution
Our ability to engage and perform daily activities relies on balancing the associated benefits
and costs. Rewards, as benefits, act as powerful motivators that help us stay focused for …
and costs. Rewards, as benefits, act as powerful motivators that help us stay focused for …
The effects of serotonin and/or noradrenaline reuptake inhibitors on impulsive-like action assessed by the three-choice serial reaction time task: a simple and valid …
I Tsutsui-Kimura, Y Ohmura, T Izumi… - Behavioural …, 2009 - journals.lww.com
Impulsivity is a pathological symptom in several psychiatric disorders, underscoring the
need for animal models of impulsive action to develop a brief screening method for novel …
need for animal models of impulsive action to develop a brief screening method for novel …
Characterization of amphetamine, methylphenidate, nicotine, and atomoxetine on measures of attention, impulsive action, and motivation in the rat: implications for …
GA Higgins, LB Silenieks, C MacMillan… - Frontiers in …, 2020 - frontiersin.org
Amphetamine (AMP), methylphenidate (MPH), and atomoxetine (ATX) are approved
treatments for ADHD, and together with nicotine (NIC), represent pharmacological agents …
treatments for ADHD, and together with nicotine (NIC), represent pharmacological agents …
The 5-HT1A/1B-receptor agonist eltoprazine increases both catecholamine release in the prefrontal cortex and dopamine release in the nucleus accumbens and …
SM Korte, J Prins, FS Van den Bergh… - European journal of …, 2017 - Elsevier
Abstract The 5-HT 1A/1B-receptor agonist eltoprazine has a behavioral drug signature that
resembles that of a variety of psychostimulant drugs, despite the differences in receptor …
resembles that of a variety of psychostimulant drugs, despite the differences in receptor …
Relationship between two forms of impulsivity in mice at baseline and under acute and sub-chronic atomoxetine treatment
M Kyriakidou, M Caballero-Puntiverio… - Progress in Neuro …, 2023 - Elsevier
Rationale Impulsivity is a symptom of various mental disorders, including attention deficit
hyperactivity disorder (ADHD), bipolar disorder, and addiction. Impulsivity is not a unitary …
hyperactivity disorder (ADHD), bipolar disorder, and addiction. Impulsivity is not a unitary …
Chronic atomoxetine treatment during adolescence decreases impulsive choice, but not impulsive action, in adult rats and alters markers of synaptic plasticity in the …
Rationale Impulsivity is a key symptom of attention-deficit hyperactivity disorder (ADHD). The
use of the norepinephrine reuptake inhibitor, atomoxetine, to treat ADHD suggests that the …
use of the norepinephrine reuptake inhibitor, atomoxetine, to treat ADHD suggests that the …